References
- Inman W. H.W. Adverse Drug Reactions: The Scale and Nature of the Problem and the Way Forward, D. Mann. Parthenon Publishing, ParkRidge, New Jersey 1987; 177
- Walker S. P., Parrish J. A. Trends and Changes in Drug Research and Development, B. C. Walker, S. R. Walker. Kluwer Academic Publishers. 1988
- Cox B. Pharmaceutical J. September 1989; 16: 329
- Wiggins S. N. Pharmaceutical Manufacturers Association, Washington, DC June, 1897
- Nicholls J. T. Post-marketing Surveillance of Adverse Reacticns to New Medicines. Medico-Pharmaceutical Forum 1978, No. 7: 4
- Case D. E., Lindup W. E. Brit. J. Pharmacol 1978; 63: 352P
- Grahame-Smith D. G. Adverse Drug Reactions: The Scale and Nature of the Problem and the Way Forward, R. D. Mann. Parthenon Publishing, Park Ridge, New Jersey 1987; 201
- Rogers A. S. Drug Intell. Clin. Pharm 1987; 21: 915
- Rawlins M. D., Thompson J. W. Textbook of Adverse Drug Reactions, D. M. Davies. Oxford University Press. 1977; 10
- Nomifensine. FDA Drug Bull 1986; 16: 15
- Feinstein A. R. Eur. J. Clin. Pharmacol 1980; 17: 1
- Edlavitch S. A. Drug Intell. Clin. Pharm 1988; 22: 68
- Hagler L., Luscombe F., Siegfried J. Drug Information. J 1987; 21: 83
- Rossi A. C., Knapp D. E., Anello C. JAMA 1983; 249: 2226
- Antumes C. M.F., Stolley P. D., Rosenshein N. B. N. Engl. J. Med 1979; 300: 9
- Herbst A. L., Ulfelder H., Poskanzer D. C. N. Engl. J. Med 1971; 284: 878
- Faich G. A., Dreis M., Tomita D. Arch. Intern. Med 1988; 148: 785
- Kennedy D. L., Perez T. H., Faich G. A. Clin. Research Prac. Drug Reg. Affairs 1990; 8: 5
- Sills J. M., Faich G. A., Milstein J. B., Turner W. M. Drug Information J 1986; 20: 151
- Faich G. A., Milstein J. B., Anello C., Baum C. Druq Information J 1987; 21: 251
- Faich G. A. New Engl. J. Med 1986; 314: 1589
- Bateman D. N., Chaplin S. Br. Med. J 1988; 296: 781
- Rossi A. C., L Bosco G. A., Faich. JAMA 1988; 259: 1203
- Scott D. H., Rosenbaum S. E., Waters W. J. R. I. Med J 1987; 70: 311
- Rosenbaum S. E., Thacher-Renshaw A., Green M., Waters W. J. Clin Research Prac. Drug Reg. Affairs 1990; 8: 13
- Walker S. R., Lumley C. E. Adverse Drug Reactions: The Scale and the Way Forward, R. D. Mann. Parthencn Publishing, Park Ridge, NJ 1987; 115
- Venning G. R. Br. Med. J 1983; 286: 365
- Koch-Weser J., Sidel V. W., Sweet R. H. N. Engl. J. Med 1969; 280: 20
- Wardell W. M., Tsianco M. C., Anavekar S. N. J. Clin. Pharmacol 1979; 19: 85
- Milstien J. B., Faich G. A., Hsu J. P. Drug Information J 1986; 20: 157
- Anonymcus. Br. Med. J 1986; 292: 1190
- Griffin J. P., Weber J. C.P. Adv. Drug React. Ac. Pois. Rev 1986; 1: 23
- Scott H. D., Thacher-Renshaw A., Rosenbaum S. E. JAMA 1990; 263: 1785
- Rogers A. S., Israel E., Smith C. R. Arch. Intern Med 1988; 148: 1596
- Rogers A. S. Clin. Research Prac. Drug Reg. Affairs 1990; 8: 29
- Fincham J. E., Szeinbach S. L. Clin. Research Prac. Drug Reg. Affairs 1990; 8: 45
- Horn M. Clin Research Prac. Drug Reg. Affairs 1990; 8: 65
- Jick H., Madsen S., Nudelman P. M. Pharmacology 1994; 4: 99
- Jick H., Walker A. M., Watkins R. N. Am. J. Epidemiol 1980; 112: 577
- Jick H., Holmes L. B., Hunter J. R. JAMA 1981; 246: 343
- Tilson H. H. Can. J. Public Health 1985; 76: 222
- McDevitt D. G., Reardon P. H.G., Browm S. V. Adverse Drug Reactions. The Scale and the Way Forward, R. D. Mann. Parthenon Publishing, ParkRidge, NJ 1987; 107
- Morse M. L., Le Boy A. A., Strom B. L. Monitoring for Drug Safety, 2nd. ed, W. H.W. Inman. MTP Press Ltd, Boston 1986; 237
- Ray W. A., Griffin M. R. Am. J. Epidemiol 1989; 129: 837
- Stergachis A. S. Drug Intell. Clin. Pharm 1988; 22: 157
- Shapiro S. Clin. Pharmacol. Ther 1989; 46: 371
- Strom B. L., Carson J. L. Clin. Pharmacol. Ther 1989; 46: 390
- Faich G. A., Stadel B. V. Clin. Pharmacol. Ther 1989; 46: 387
- Jick H., Walker A. M. Clin. Pharmacol. Ther 1989; 46: 478
- Faich B. A. Clin. Pharmacol. Ther 1989; 46: 479
- Tilson H. H. Clin. Pharmacol. Ther 1989; 46: 480
- Inman W. H.W., Rawson N. S.B., Wilton L. V. Monitoring for Drug Safety, 2nd. ed, W. H.W. Inman. MTP Press Ltd, Boston 1986; 213
- Drug Surveillance Research Unit. FEM News 1988; 5
- Inman W. H.W., Rawson N. S.B., Wilton L. V. Br. Med. J 1988; 297: 826
- Bateman D. N., Darling W. M., Boys R., Rawlins M. D. Quart. J. Med 1989; 71: 307
- Anonymous. Lancet 1989; II: 139
- Smith C. G. Regul. Toxicol. Pharmacol 1985; 5: 241
- Mathieu M. New Drug Development: A Regulatory Overview. Parexel, Cambridge, MA 1990